Spyryx Biosciences, Inc.
http://www.spyryxbio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Spyryx Biosciences, Inc.
Pipeline Watch: Phase III Progress With Nimotuzumab, Solriamfetol, And Upadacitinib
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Start-Up Execs On The Move, June 2015
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Venture Funding Deals, June 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2015.
Out Of The Blocks, March 2015
Brief profiles of these recently formed companies: Capsos Medical, Encycle Therapeutics, MiNDERA, and Spyryx BioSciences.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
- Pulmonary
-
Drug Delivery
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice